Cytoprotective and suicidal signaling in oxidative stress

Biological Research

Volumn 43, Issue 3, 2010, Pages 363-369

  Videla, Luis A ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Insulin resistance; Liver preconditioning; Non alcoholic fatty liver disease; Obesity; Oxidative stress; Thyroid hormone

Indexed keywords

EID: 78650064902     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602010000300014     Document Type: Article

References (52)

1. AGRAWAL A, CHA-MOLSTAD H, SAMOLS D, KUSHNER I (2003) Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology 108: 539-547.
2. ANGULO P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
3. ARAYA J, RODRIGO R, VIDELA LA, THIELEMANN L, ORELLANA M, PETTINELLI P, PONIACHIK J (2004) Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci 106: 635-643.
4. ARONIS A, MADAR Z, TIROSH O (2005) Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med 38: 1221-1230.
5. BABIOR BM (2004) NADPH Oxidase. Curr Opin Immunol 16: 42-47.
6. BOVERIS A, REPETTO MG, BUSTAMANTE J, BOVERIS AD, VALDEZ LB (2008) The concept of oxidative stress in pathology. In: ALVAREZ S, EVELSON P (eds) Free Radical Pathophysiology. Kerala, India: Transworld Research Network, pp:1-17.
7. CARO AA, CEDERBAUM AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44: 27-42.
8. CASILLAS-RAMÍREZ A, MOSBAH IB, RAMALHO F, ROSELLÓ-CATAFAU J, PERALTA C (2006) Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79: 1881-1894.
9. CLARKE SD (2004) The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 15: 13-18.
10. DRÖGE W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
11. ELIZONDO A, ARAYA J, RODRIGO R, SIGNORINI C, SGHERRI C, COMPORTI M, PONIACHIK J, VIDELA LA (2008) Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. Biol Res 41: 59-68.
12. EVANS JL, MADDUX BA, GOLDFINE ID (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7: 1040-1052.
13. FAUSTO N, CAMPBELL JS, RIEHLE KJ (2006) Liver regeneration. Hepatology 43: S45-S53.
14. FERNÁNDEZ V, BARRIENTOS X, KIPREOS K, VALENZUELA A, VIDELA LA (1985) Superoxide radical generation, NADPH oxidase activity, and cytochrome P450 content in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 117: 496-501.
15. FERNÁNDEZ V, VIDELA LA (1993) Influence of hyperthyroidism on superoxide radical and hydrogen peroxide production by rat liver submitochondrial particles. Free Radic Res Commun 18: 329-335.
16. FERNÁNDEZ V, VIDELA LA (1996) Biochemical aspects of cellular antioxidant systems. Biol Res 29: 177-182.
17. FERNÁNDEZ V, VIDELA LA, TAPÌA G, ISRAEL Y (2002) Increases in tumor necrosis factor-a in response to thyroid hormone-induced liver oxidative stress in the rat. Free Radic Res 36: 719-725.
18. FERNÁNDEZ V, MASSA L, QUIÑONES L, SIMON-GIAVAROTTI KA, GIAVAROTTI L, D'ALMEIDA V, AZZALIS LA, JUNQUEIRA VBC, VIDELA LA (2003) Effects of γ-hexachlorocyclohexane and L-3,3,5-triiodothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation. Biol Res 36: 359-365.
19. FERNÁNDEZ V, TAPIA G, VARELA P, VIDELA LA (2005a) Redox regulation of thyroid hormone-induced Kupffer cell-dependent IκB-α phosphorylation in relation to inducible nitric oxide synthase expression. Free Radic Res 39: 411-418.
20. FERNÁNDEZ V, TAPIA G, VARELA P, CASTILLO I, MORA C, MOYA F, ORELLANA M, VIDELA LA (2005b) Redox-up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of κB-α phosphorylation and nuclear factor-κB activation. J Endocrinol 186: 539-547.
21. FERNÁNDEZ V, REYES S, BRAVO S, SEPÚLVEDA R, ROMANQUE P, SANTANDER G, CASTILLO I, VARELA P, TAPIA G, VIDELA LA (2007a) Involvement of Kupffer cell-dependent signaling in T3-induced hepatocyte proliferation in vivo. Biol Chem 388: 831-837.
22. FERNÁNDEZ V, CASTILLO I, TAPIA G, ROMANQUE P, URIBEECHEVARRÍA S, URIBE M, CARTIER-UGARTE D, SANTANDER G, VIAL MT, VIDELA LA (2007b) Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology 45: 170-177.
23. FERNÁNDEZ V, TAPIA G, VARELA P, GAETE L, VERA G, MORA C, VIAL MT, VIDELA LA (2008) Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats. Free Radic Biol Med 44: 1724-1731.
24. FERNÁNDEZ V, VIDELA LA (2009) Kupffer cell-dependent signaling in thyroid hormone calorigenesis: possible applications for liver preconditioning. Curr Signal Trans Ther 4:144-151.
25. GLOIRE G, LEGRAND-POELS S, PIETTE J (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505.
26. GOMES LF, LORENTE S, SIMON-GIAVAROTTI KA, ARECO KN, ARAUJO-PERES C, VIDELA LA (2004) Tri-iodothyronine differentially induces Kupffer cell ED1/ED2 subpopulations. Mol Aspects Med 2004; 25: 183-190.
27. HIRANO T, ISHIHARA K, HIBI M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556.
28. HOUSTIS N, ROSEN ED, LANDER ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440; 944-948.
29. HUH K, KWON TH, KIM JS, PARK JM (1998) Role of the hepatic xanthine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver. Arch Pharmac Res 21: 236-240.
30. KOBAYASHI M, YAMAMOTO M (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7: 385-394.
31. MALAGUARNERA L, DI ROSA M, ZAMBITO AM, DELL OMBRA N, NICOLRTTI F, MALAGUARNERA M (2006) Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 55: 1313-1320.
32. ORELLANA M, RODRIGO R, VARELA N, ARAYA J, PONIACHIK J, CSENDES A, SMOK G, VIDELA LA (2006) Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol Res 34: 57-63.
33. POLI G, LEONARDUZZI G, BIASI F, CHIARPOTTO E (2004) Oxidative stress and cell signaling. Curr Med Chem 11: 1163-1182.
34. RAM PA, WAXMAN DJ (1992) Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. J Biol Chem 267: 3294-3301.
35. RAMADORI G, CHRIST B (1999) Cytokines and the hepatic acute-phase response. Sem Liver Dis 19: 141-155.
36. ROMANQUE P, URIBE M, VIDELA LA (2005) Mecanismos moleculares en el daño por isquemia-reperfusión y en el preacondicionamiento isquémico. Rev Méd Chile 133: 469-476.
37. SCHWARTZ HL, OPPENHEIMER JH (1978) Physiologic and biochemical actions of thyroid hormone. Pharmacol Ther Part B 3: 349-376.
38. SEKI S, KITADA T, YAMADA T, SAKAGUCHI H, NAKATANI K, WAKASA K (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37: 56-62.
39. SIES H (1986) Biochemistry of oxidative stress. Angew Chem Int Ed Engl 25: 1058-1071.
40. TAPIA G, PEPPER I, SMOK G, VIDELA LA (1997) Kupffer cell function in thyroid hormone-induced liver oxidative stress in the rat. Free Radic Res 26: 267-279.
41. TAPIA G, FERNÁNDEZ V, VARELA P, CORNEJO P, GUERRERO J, VIDELA LA (2003) Thyroid hormone-induced oxidative stress triggers nuclear factor-κB activation and cytokine gene expression in rat liver. Free Radic Biol Med 35: 257-265.
42. TAPIA G, FERNÁNDEZ V, PINO C, ARDILES R, VIDELA LA (2006) The acute-phase response of the liver in relation to thyroid hormoneinduced redox signaling. Free Radic Biol Med 40: 1628-1635.
43. TSUKAMOTO H (2002) Redox regulation of cytokine expression in Kupffer cells. Antiox Redox Signal 4: 741-748.
44. VARELA P, TAPIA G, FERNÁNDEZ V, VIDELA LA (2006) The role of thyroid hormone calorigenesis in the redox regulation of gene expression. Biol Res 39: 611-617.
45. VENDITTI P, DI MEO S (2006) Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 63: 414-434.
46. VIDELA LA, FERNÁNDEZ V (1988) Biochemical aspects of cellular oxidative stress. Arch Biol Med Exp 21: 85-92.
47. VIDELA LA, RODRIGO R, ARAYA J, PONIACHIK J (2004a) Oxidative stress and depletion of long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 37: 1499-1507.
48. VIDELA LA, RODRIGO R, ORELLANA M, FERNÁNDEZ V, TAPIA G, QUIÑONES L, VARELA N, CONTRERAS J, LAZARTE R, CSENDES A, ROJAS J, MALUENDA F, BURDILES P, DÍAZ JC, SMOK G, THIELEMANN L, PONIACHIK J (2004b) Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci 106: 261-268.
49. VIDELA LA, RODRIGO R, ARAYA J, PONIACHIK J (2006) Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 12: 555-558.
50. VIDELA LA, FERNÁNDEZ V, TAPIA G, VARELA P (2007) Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front Biosc 12: 1220-1228.
51. VIDELA LA (2008) Oxidative stress and insulin resistance as interdependent pathogenic mechanisms in non-alcoholic fatty liver disease associated with obesity. In: ALVAREZ S, EVELSON P (eds) Free Radical Pathophysiology. Kerala, India: Transworld Research Network, pp:369-385.
52. VIDELA LA, TAPIA G, RODRIGO R, PETTINELLI P, HAIM D, SANTIBAÑEZ C, ARAYA AV, SMOK G, CSENDES A, GUTIERREZ L, ROJAS J, CASTILLO J, KORN O, MALUENDA F, DÍAZ JC, RENCORET G, PONIACHIK J (2009) Liver NF-κB and AP-1 DNA binding in obese patients. Obesity 17: 973-979.